Assoc. Prof.

Fatmahan ATALAR


Instıtute of Chıld Health

Dahili Tıp Bilimleri Bölümü

Department of Family Health

Education Information

2007 - 2008

2007 - 2008

Post Doctorate

Johannes Kepler Universitaet Linz, Engineering And Natural Sciences, Austria

2001 - 2002

2001 - 2002

Post Doctorate

Université Louis-Pasteur: Strasbourg I, Inserm Unite 424, France

2000 - 2001

2000 - 2001

Post Doctorate

University Of Essex, Faculty Of Sciences And Health, School Of Biological Sciences, United Kingdom

1994 - 1997

1994 - 1997

Doctorate

University Of Essex, Faculty Of Science And Health, School Of Biological Sciences, United Kingdom

Foreign Languages

C1 Advanced

C1 Advanced

English

C1 Advanced

C1 Advanced

French

B1 Intermediate

B1 Intermediate

Spanish

Certificates, Courses and Trainings

2020

2020

European Joint Programme Rare Diseases-Online Workshop Implementing Biomedical Research Projects: The Complete Workflow from Concept, ELSI and Privacy Considerations to High-Quality Biobanking

Health&Medicine

European Joint Programme Rare Diseases

Research Areas

Life Sciences, Molecular Biology and Genetics, Genetic Disorders, Natural Sciences

Academic Titles / Tasks

2019 - Continues

2019 - Continues

Associate Professor

Istanbul University, Instıtute Of Chıld Health, Dahili Tıp Bilimleri Bölümü

2014 - 2017

2014 - 2017

Professor

Muhimbili University Of Health And Allied Sciences, Temel Bilimler, Biyokimya

Managerial Experience

2017 - 2018

2017 - 2018

Head of Department

İstanbul Üniversitesi

2014 - 2017

2014 - 2017

Director of the Center

Muhimbili University Health And Allied Sciences

Representation and Promotion Activities

Muhimbili İnsan Genetik Laboratuvarı Kurulması

Institutional Representation, Muhimbili Tıp Fakültesi, Tanzania, Dar-Es-Salaam, 2015 - 2018

Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes

2021

2021

Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19

Görmez S., Değirmencioğlu A., Paudel A., Atalar F. , Erdim R., Dağdelen S., et al.

Bratislava Medical Journal-Bratislavske Lekarske Listy, vol.122, no.8, pp.579-586, 2021 (Journal Indexed in SCI Expanded) Creative Commons License Sustainable Development

2019

2019

Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.

GORMEZ S., ERDIM R., AKAN G., CAYNAK B., DURAN C., GUNAY D., et al.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, vol.46, pp.107192, 2019 (Journal Indexed in SCI) identifier identifier identifier

2019

2019

Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.

Adolf I., Akan G., Mselle T., Dharsee N., Namkınga L., Atalar F.

Asian Pacific journal of cancer prevention : APJCP, vol.20, pp.3465-3472, 2019 (Journal Indexed in SCI Expanded) Sustainable Development identifier identifier

2015

2015

PAI-1 and TNF-a profiles of adipose tissue inobese cardiovascular disease patients

BİLGİÇ GAZİOĞLU S. , ATALAR F. , Erten G.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, vol.8, no.12, pp.15919-15915, 2015 (Journal Indexed in SCI Expanded) Sustainable Development

2015

2015

PAI-1 and TNF-alpha profiles of adipose tissue in obese cardiovascular disease patients

Gazioglu S. B. , Akan G., Atalar F. , Erten G.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, vol.8, no.12, pp.15919-15925, 2015 (Journal Indexed in SCI) Creative Commons License Sustainable Development identifier identifier identifier

2013

2013

Identification of a Novel BRCA2 and CHEK2 A-C-G-C Haplotype in Turkish Patients Affected with Breast Cancer

Haytural H., Yalcinkaya N., Akan G., ARIKAN S., Ozkok E. , Cakmakoglu B. , et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.5, pp.3229-3235, 2013 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

2013

2013

Growth Hormone/Insulin-Like Growth Factor-1 Axis as Related to Body Mass Index in Patients with Idiopathic Short Stature

Cengiz P., Bas F. , Atalar F. , Ucar A., Darendeliler F. , Akan G., et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, vol.5, no.1, pp.13-19, 2013 (Journal Indexed in SCI) identifier identifier identifier

2009

2009

CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children.

Baş F. , Kayserili H., Darendeliler F., Uyguner O., Günöz H., Yüksel A., et al.

Journal of clinical research in pediatric endocrinology, vol.1, pp.116-28, 2009 (Journal Indexed in SCI Expanded) Creative Commons License identifier identifier

Articles Published in Other Journals

2009

2009

CYP21A2 gene mutations in congenital adrenal hyperplasia: Genotype-phenotype correlation in Turkish children

BAŞ F. , Kayserili H., DARENDELİLER F. F. , BUNDAK R. , UYGUNER Z. O. , GÜNÖZ H. , et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, vol.1, no.3, pp.116-128, 2009 (Refereed Journals of Other Institutions)

Refereed Congress / Symposium Publications in Proceedings

2020

2020

Circulating lncRNA ANRIL: a potential biomarker in Tanzanian patients with coronary artery disease

Atalar F. , Akan G., Janabi M.

European Human Genetics Virtual Conference, Berlin, Germany, 6 - 09 June 2020, pp.1124

2020

2020

DIO2 Thr92Ala Reduces Deiodinase 2 Activity and Serum T3 Levels in Patients with Schizophrenia.

Atalar F. , Özgen Ö.

European Human Genetics Virtual Conference, 6 June - 09 September 2020, pp.1164

0

0

Decreased WNT5A and FZ5 mRNA Levels contributes to Acute Lymphoblastic Leukemia (ALL)

SAYİTOĞLU M. , HATIRNAZ O., ATALAR F. , ÖZBEK U.

30th World Congress of the International Society of Hematology, İstanbul, Turkey, pp.196

0

0

Proinflamatuvar Bir Mediatör Olan Osteopontin ve Obezite

TARHAN T., ATALAR F. , BAŞ F. , AKAN G., Demir G., DARENDELILER F., et al.

Endokrin Hastalıklar ve Genetik Sempozyumu, Bolu, Turkey, pp.113 Sustainable Development

0

0

İdiyopatik Boy Kısalığı Etiyopatogenezinde IGF-1 Gen Polimorfizmi Araştırılması

TEKCAN D., BAŞ F. , ATALAR F. , AKAN G., TARHAN T., DARENDELILER F.

33. Pediatri Günleri ve 12. Pediatri Hemşireliği Günleri, İstanbul, Turkey, pp.13

0

0

Leptin ve Leptin Reseptör Polimorfizmlerinin Çocukluk Çağı Obezitesi ile İlişkisi

AKAN G., ATALAR F. , BAŞ F. , Demir G., TARHAN T., DARENDELILER F., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.160

0

0

Crosstalk Between T-Cadherin and Wnt/B-Catenin Pathways in Cancer

FEJZULLAHU A., TEKINER T. A. , ERDEM M., Anak S., ÖZBEK U. , ATALAR F.

European Society of Human Genetics Conference (ESHG) 2009, Austria, pp.166 Sustainable Development

0

0

Konjenital Adrenal Hiperplazide Pro12Ala ve Val103 Polimorfizmlerinin İncelenmesi

TARHAN T., ATALAR F. , BAŞ F. , AKAN G., Demir G., DARENDELILER F., et al.

XIII. Ulusal Pediatrik Endokrinoloji ve Diyabet Kongresi, Antalya, Turkey, pp.124

0

0

WNT Pathway Mutations in Acute Leukemia Patients

SAYİTOĞLU M. , ATALAR F. , HATIRNAZ NG Ö. , ERBİLGİN Y. , ÖZBEK U.

12th Congress of European-Hematology-Association (EHA), Austria, pp.55

0

0

“Leptin, Leptin Receptor, MC4R, PPAR Gamma and Osteopontin Gene Polymorphisms in Obese and Overweight Children”

ATALAR F. , BAŞ F. , AKAN G., TARHAN T., DARENDELILER F., AYDIN B. K. , et al.

49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.79

0

0

“Expression of IGF-1, IGFBP-3, IGF-1R Genes in Idiopathic Short Stature

CENGIZ P., BAŞ F. , BUNDAK R. , ATALAR F. , DARENDELILER F., AYDIN B. K. , et al.

49th Annual Meeting of the European Society of Pediatric Endocrinology (ESPE), Czech Republic, pp.198

2019

2019

Implication of HLA-G+3142G>C Polymorphism and Soluble HLA-G in Mastectomized Breast Cancer Patients in Tanzania

Atalar F. , Chatita A. I.

. 12th Conference of African Society of Human Genetics, Bamako, Mali, 19 September 2019 - 21 September 2020, pp.94 Sustainable Development

2018

2018

Evaluation of Association Between Common SNPs on 9p21.3 Region and Coronary Artery Disease in Tanzanian Population.

ATALAR F. , Mbugi E., Akan G., Janabi M., Kisenge P., Sanga T.

5th World Congress on Epigenetics and Chromosome, İstanbul, Turkey, 15 November - 16 October 2018, pp.74-75 Sustainable Development

2018

2018

Association of Chromosome 9p21.3 Region with Increased Risk of Coronary Artery Disease in Northern Tanzanian Patients.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

34th Turkish Cardiology Congress with International Participation, Antalya, Turkey, 20 - 23 October 2018, pp.145-147

2018

2018

Polymorphisms on Chromosome 9p21.3 Modify Susceptibility to Coronary Artery Disease and the Severity of Coronary Atherosclerosis in Tanzanian Population.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

11th Conference of the AfSHG - African Society of Human Genetics., Darüsselam, Tanzania, 19 - 21 September 2018, pp.19-20 Sustainable Development

2018

2018

Association of 9p21.3 With The Risk of Coronary Artery Disease in Tanzanian Patients

Akan G., Kisenge P., Mbugi E., Sanga T., Janabi M., ATALAR F.

The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116

2018

2018

Polymorphisms in 9p21.3 locus are associated with coronary artery disease in Northern Tanzanian patients.

Akan G., Mbugi E., Janabi M., Kisenge P., Sanga T., ATALAR F.

The Sixth MUHAS Scientific Conference., Darüsselam, Tanzania, 2 - 03 July 2018, pp.114-116

2006

2006

Upregulation of FZ5 results in abberant expression of beta-catenin and LEF/TCF complex in acute myeloid leukemia.

Atalar F. , Hatirnaz O., Erbilgin Y. , Ozbek U., Sayitoglu M. , Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108 identifier

2006

2006

Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.

Sayitoglu M. , HATIRNAZ O., Erbilgin Y. , Atalar F. , Ozbek U.

48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108 identifier

2006

2006

Acylation stimulating protein and complement c3 mRNA expression in metabolic syndrome

DUMAN B. S. , CIFTCI C., Atalar F. , DEMIRKAN A., VURAL B. , CAGATAY P. , et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.205 identifier

2006

2006

11 beta-HSD type 1 is responsible for low plasma hdl-cholesterol and abdominal obesity in metabolic syndrome patients

Atalar F. , VURAL B. , CIFTCI C., DEMIRKAN A., SUSLEYICI-DUMAN B., CAGATAY P. , et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.203 Sustainable Development identifier

2006

2006

Quantitative expression analysis of glucocorticoid receptor (GcR) gene in metabolic syndrome

DEMIRKAN A., Atalar F. , VURAL B. , DUMAN B. S. , CIFTCI C., GUNAY G., et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204 identifier

2006

2006

The role of FABP4 gene expression in metabolic syndrome patients with previous myocardial infarction

VURAL B. , Atalar F. , DEMIRKAN A., CIFTCI C., DUMAN B. S. , CAGATAY P. , et al.

31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.204 identifier

Books & Book Chapters

2008

2008

General laboratory safety regulations

ATALAR F.

in: Genomik Uygulamalar, Özalpan A., Ünsal NP., Editor, T.C. İstanbul Kültür Üniversitesi Yayınları, İstanbul, pp.57-78, 2008

Supported Projects



Scholarships

1999 - 2002

1999 - 2002

Araştırma Bursu

Official Institutions of Foreign Countries

1995 - 1997

1995 - 1997

Doktora Bursu

NATO

Citations

Total Citations (WOS): 404

h-index (WOS): 8

Jury Memberships

January-2021

January 2021

Doctorate

Doctorate - Kocaeli Üniversitesi